Almoosa Health Co.

Almoosa Health Co. is a Saudi Arabian healthcare provider operating in the Medical Care Facilities industry. The company offers a comprehensive range of medical services, including inpatient and outpatient care, surgical procedures, diagnostic services, and emergency medicine. It manages multiple hospitals and medical centers across the Eastern Province of Saudi Arabia, with a focus on delivering high-quality healthcare to local communities. Almoosa Health is listed on the Saudi Exchange under ticker 4018.

Revenue is primarily generated from patient care services, including hospital stays, surgeries, outpatient consultations, and diagnostic tests. The company also derives income from ancillary services such as pharmacy sales, laboratory services, and medical equipment rentals. Payment sources include private insurance, government programs, and out-of-pocket payments from patients. The recent financial data shows revenue of approximately 348-388 million SAR per quarter, with net income fluctuating significantly due to operational costs and investment cycles.

The healthcare sector in Saudi Arabia is highly regulated and competitive, with both public and private providers. Almoosa Health positions itself as a regional private healthcare leader in the Eastern Province, competing with other hospital groups and specialized medical centers. Its financial metrics indicate moderate profitability (profit margin ~14.5%) but high debt levels (882M SAR vs. 32M cash) and negative free cash flow yield (-8.46%), suggesting capital-intensive operations and ongoing investment. The company's EV/EBITDA of 18.74 reflects a premium valuation relative to earnings.

Almoosa Health primarily serves patients in the Eastern Province of Saudi Arabia, including residents of Al-Ahsa and surrounding areas. Its target audience includes individuals seeking private medical care, families, and corporate clients with health insurance. The company also serves government-referred patients and participates in public health programs. With a market cap of 5.29B SAR, it is a mid-cap player in the Saudi healthcare market, focusing on regional rather than national or international expansion.

An auto-generated descriptive profile based on company data, for informational purposes only.